Discover
SPRY
ARS Pharmaceuticals, Inc.
7.94
2 x 5.91
2 x 10.21
bid
ask
-
0.07
0.87%
2 @ 04:00 PM
7.95 +0.01 (0.13%)
| Ytd | -31.85% | |
| 1y | -52.60% |
7.89
day range
8.21
6.66
52 week range
18.63
| Open | 8.00 | Prev Close | 8.01 | Low | 7.89 | High | 8.21 | Mkt Cap | 788.47M |
| Vol | 1.15M | Avg Vol | 1.79M | EPS | -2.00 | P/E | N/A | Forward P/E | -11.01 |
| Beta | 0.83 | Short Ratio | 13.70 | Inst. Own | 95.47% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-13 | 50-d Avg | 8.70 | 200-d Avg | 9.33 | 1yr Est | 28.80 |
| Income Statement | |||
| Total Revenue | 22.68M | ||
| Revenues (USD) | 22.68M | ||
| Cost of Revenue | 6.29M | ||
| Gross Profit | 16.40M | ||
| Operating Expenses | 76.54M | ||
| Research and Development Expense | 4.34M | ||
| Selling, General and Administrative Expense | 72.20M | ||
| Operating Income | -60.14M | ||
| Interest Expense | 2.44M | ||
| Net Income | -60.62M | ||
| Net Income Common Stock | -60.62M | ||
| Net Income Common Stock (USD) | -60.62M | ||
| Consolidated Income | -60.62M | ||
| Earnings per Basic Share | -0.61 | ||
| Earnings per Basic Share (USD) | -0.61 | ||
| Earnings per Diluted Share | -0.61 | ||
| Earning Before Interest & Taxes (EBIT) | -58.18M | ||
| Earning Before Interest & Taxes (USD) | -58.18M | ||
| Weighted Average Shares | 99.30M | ||
| Weighted Average Shares Diluted | 99.30M | ||
| Balance Sheet | |||
| Cash and Equivalents | 24.32M | ||
| Cash and Equivalents (USD) | 24.32M | ||
| Investments | 176.65M | ||
| Investments Current | 176.65M | ||
| Trade and Non-Trade Receivables | 28.66M | ||
| Current Assets | 245.24M | ||
| Property, Plant & Equipment Net | 2.29M | ||
| Total Assets | 287.57M | ||
| Total Debt | 171.20M | ||
| Current Liabilities | 49.61M | ||
| Debt Non-Current | 171.20M | ||
| Total Liabilities | 226.26M | ||
| Accumulated Retained Earnings (Deficit) | -355.22M | ||
| Accumulated Other Comprehensive Income | -96.00K | ||
| Shareholders Equity | 61.31M | ||
| Shareholders Equity (USD) | 61.31M | ||
| Assets Non-Current | 42.34M | ||
| Total Debt (USD) | 171.20M | ||
| Deferred Revenue | 757.00K | ||
| Goodwill and Intangible Assets | 14.18M | ||
| Inventory | 32.04M | ||
| Liabilities Non-Current | 176.65M | ||
| Trade and Non-Trade Payables | 48.26M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 397.00K | ||
| Net Cash Flow from Financing | 159.00K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -17.00M | ||
| Issuance (Purchase) of Equity Shares | 62.00K | ||
| Issuance (Repayment) of Debt Securities | 97.00K | ||
| Net Cash Flow from Investing | 27.79M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | 27.79M | ||
| Net Cash Flow from Operations | -44.95M | ||
| Share Based Compensation | 7.42M | ||